Literature DB >> 12244039

Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors.

Birgitte Holst1, Christian E Elling, Thue W Schwartz.   

Abstract

An endogenous metal-ion site in the melanocortin MC1 and MC4 receptors was characterized mainly in transiently transfected COS-7 cells. ZnCl(2) alone stimulated signaling through the Gs pathway with a potency of 11 and 13 microm and an efficacy of 50 and 20% of that of alpha-melanocortin stimulating hormone (alpha-MSH) in the MC1 and MC4 receptors, respectively. In the presence of peptide agonist, Zn(II) acted as an enhancer on both receptors, because it shifted the dose-response curves to the left: most pronounced was a 6-fold increase in alpha-MSH potency on the MC1 receptor. The effect of the metal ion appeared to be additive, because the maximal cAMP response for alpha-MSH in the presence of Zn(II) was 60% above the maximal response for the peptide alone. The affinity of Zn(II) could be increased through binding of the metal ion in complex with small hydrophobic chelators. The binding affinities and profiles were similar for a number of the 2,2'-bipyridine and 1,10-phenanthroline analogs in complex with Zn(II) in the MC1 and MC4 receptors. However, the potencies and efficacies of the metal-ion complexes were very different in the two receptors, and close to full agonism was obtained in the MC1 receptor. Metal ion-chelator complexes having antagonistic properties were also found. An initial attempt to map the metal-ion binding site in the MC1 receptor indicated that Cys(271) in extracellular loop 3 and possibly Asp(119) at the extracellular end of TM-III, which are both conserved among all MC receptors, are parts of the site. It is concluded that the function of the MC1 and MC4 receptors can be positively modulated by metal ions acting both as partial agonists and as potentiators for other agonists, including the endogenous peptide ligand alpha-MSH at Zn(II) concentrations that could be physiological. Furthermore, the metal ion-chelator complexes may serve as leads in the development of novel melanocortin receptor modulators.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244039     DOI: 10.1074/jbc.M202103200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

Authors:  Irina D Pogozheva; Biao-Xin Chai; Andrei L Lomize; Tung M Fong; David H Weinberg; Ravi P Nargund; Michael W Mulholland; Ira Gantz; Henry I Mosberg
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

2.  Determination of the melanocortin-4 receptor structure identifies Ca2+ as a cofactor for ligand binding.

Authors:  Jing Yu; Luis E Gimenez; Ciria C Hernandez; Yiran Wu; Ariel H Wein; Gye Won Han; Kyle McClary; Sanraj R Mittal; Kylie Burdsall; Benjamin Stauch; Lijie Wu; Sophia N Stevens; Alys Peisley; Savannah Y Williams; Valerie Chen; Glenn L Millhauser; Suwen Zhao; Roger D Cone; Raymond C Stevens
Journal:  Science       Date:  2020-04-24       Impact factor: 47.728

3.  Stabilizing effect of Zn2+ in native bovine rhodopsin.

Authors:  Paul S-H Park; K Tanuj Sapra; Michał Koliński; Sławomir Filipek; Krzysztof Palczewski; Daniel J Muller
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

Review 4.  The role of metals in mammalian olfaction of low molecular weight organosulfur compounds.

Authors:  Eric Block; Victor S Batista; Hiroaki Matsunami; Hanyi Zhuang; Lucky Ahmed
Journal:  Nat Prod Rep       Date:  2017-05-10       Impact factor: 13.423

5.  Experimental evaluation of the generalized vibrational theory of G protein-coupled receptor activation.

Authors:  Ross D Hoehn; David E Nichols; John D McCorvy; Hartmut Neven; Sabre Kais
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-12       Impact factor: 11.205

6.  Small-molecule agonists for the glucagon-like peptide 1 receptor.

Authors:  Lotte Bjerre Knudsen; Dan Kiel; Min Teng; Carsten Behrens; Dilip Bhumralkar; János T Kodra; Jens J Holst; Claus B Jeppesen; Michael D Johnson; Johannes Cornelis de Jong; Anker Steen Jorgensen; Tim Kercher; Jarek Kostrowicki; Peter Madsen; Preben H Olesen; Jacob S Petersen; Fritz Poulsen; Ulla G Sidelmann; Jeppe Sturis; Larry Truesdale; John May; Jesper Lau
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

7.  Molecular and functional analysis of human β-defensin 3 action at melanocortin receptors.

Authors:  Matthew A Nix; Christopher B Kaelin; Tina Ta; Allison Weis; Gregory J Morton; Gregory S Barsh; Glenn L Millhauser
Journal:  Chem Biol       Date:  2013-06-20

8.  Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.

Authors:  Zhimin Xiang; Bettina Proneth; Marvin L Dirain; Sally A Litherland; Carrie Haskell-Luevano
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

9.  Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a.

Authors:  Felipe F Casanueva; Jesus P Camiña; Marcos C Carreira; Yolanda Pazos; Jozsef L Varga; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

10.  Conserved rhodopsin intradiscal structural motifs mediate stabilization: effects of zinc.

Authors:  Scott Gleim; Aleksandar Stojanovic; Eric Arehart; Daniel Byington; John Hwa
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.